Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of AMG 714 in Adult Patients With Celiac Disease [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating AMG 714 for efficacy and safety in adults with Celiac Disease has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Celiac Disease

Drugs mentioned

• AMG 714

Snippet

Sponsor: Amgen | Conditions: Celiac Disease | Phase 2 | Status: COMPLETED | Results posted: 2019-12-03